纵横研报
Ticker Detail

688338.SHG

¥30.31-0.75% 赛科希德 Medical Devices
00Reports China 医疗健康
Beijing Succeeder Technology Inc
医疗健康 · 医疗器械

Beijing Succeeder Technology Inc. engages in the research, development, production, and sales of testing instruments, reagents, and consumables in the field of in vitro diagnostics for thrombosis and hemostasis in China and internationally. The company offers coagulation testers, hemorheology testers, erythrocyte sedimentation rate and hematocrit testers, platelet aggregation testers, blood rheology analyzer, diagnostic reagents, and quality control products, as well as automated equipment with supporting testing instruments. Its products are used in the prevention, screening, diagnosis, and monitoring of thrombophilia and hemorrhagic diseases, such as stroke, coronary heart disease, and venous thromboembolism. Beijing Succeeder Technology Inc. was founded in 2003 and is based in Beijing, China.

MARKET 市值 3.12B CNY PE 35.9x 52W ¥23.51 – ¥35.71 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -12.2% ROE 5.1% 营业利润率 32.9% 净利润率 33.7%
ANALYST 股息率 0.95%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制